Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Ulcerative | 71 | 2024 | 1926 | 10.970 |
Why?
|
Crohn Disease | 67 | 2024 | 2294 | 9.570 |
Why?
|
Colitis, Microscopic | 20 | 2024 | 71 | 8.470 |
Why?
|
Inflammatory Bowel Diseases | 52 | 2024 | 2442 | 6.340 |
Why?
|
Colitis, Collagenous | 10 | 2024 | 25 | 4.150 |
Why?
|
Colitis, Lymphocytic | 11 | 2024 | 23 | 3.920 |
Why?
|
Contraceptives, Oral | 7 | 2022 | 561 | 2.720 |
Why?
|
Sweden | 33 | 2024 | 1382 | 2.060 |
Why?
|
Gastrointestinal Agents | 10 | 2020 | 510 | 1.320 |
Why?
|
Celiac Disease | 6 | 2024 | 820 | 1.210 |
Why?
|
Diverticulum | 2 | 2020 | 137 | 1.170 |
Why?
|
Colorectal Neoplasms | 15 | 2023 | 6982 | 1.130 |
Why?
|
Risk Factors | 80 | 2024 | 74976 | 1.120 |
Why?
|
Prospective Studies | 71 | 2023 | 54962 | 1.110 |
Why?
|
Sick Leave | 4 | 2020 | 105 | 1.070 |
Why?
|
Estrogen Replacement Therapy | 4 | 2018 | 1209 | 1.050 |
Why?
|
Incidence | 40 | 2024 | 21547 | 1.000 |
Why?
|
Biological Therapy | 7 | 2021 | 140 | 0.980 |
Why?
|
Reproductive History | 3 | 2018 | 210 | 0.930 |
Why?
|
Colitis | 3 | 2024 | 1242 | 0.870 |
Why?
|
Proportional Hazards Models | 26 | 2024 | 12562 | 0.870 |
Why?
|
Intra-Abdominal Fat | 2 | 2018 | 625 | 0.800 |
Why?
|
Budesonide | 3 | 2021 | 162 | 0.800 |
Why?
|
Tuberculosis, Gastrointestinal | 2 | 2019 | 20 | 0.800 |
Why?
|
Gastroenteritis | 2 | 2021 | 235 | 0.770 |
Why?
|
Tooth Loss | 1 | 2023 | 200 | 0.760 |
Why?
|
Diet | 8 | 2023 | 8088 | 0.750 |
Why?
|
Registries | 17 | 2021 | 8384 | 0.730 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2024 | 301 | 0.730 |
Why?
|
Middle Aged | 99 | 2024 | 223737 | 0.710 |
Why?
|
Humans | 185 | 2024 | 768970 | 0.710 |
Why?
|
Adult | 107 | 2024 | 223851 | 0.700 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.690 |
Why?
|
Periodontal Diseases | 1 | 2023 | 455 | 0.680 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.650 |
Why?
|
Female | 125 | 2024 | 397515 | 0.650 |
Why?
|
Case-Control Studies | 27 | 2024 | 22296 | 0.640 |
Why?
|
Colonoscopy | 10 | 2024 | 1410 | 0.610 |
Why?
|
Colectomy | 4 | 2019 | 699 | 0.610 |
Why?
|
Prevalence | 15 | 2024 | 15879 | 0.600 |
Why?
|
Follow-Up Studies | 33 | 2023 | 39394 | 0.590 |
Why?
|
Proton Pump Inhibitors | 4 | 2020 | 552 | 0.590 |
Why?
|
Diphosphonates | 2 | 2013 | 634 | 0.580 |
Why?
|
Proctitis | 1 | 2017 | 40 | 0.580 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 554 | 0.580 |
Why?
|
Bismuth | 2 | 2018 | 29 | 0.530 |
Why?
|
Iron, Dietary | 1 | 2017 | 148 | 0.530 |
Why?
|
Salicylates | 2 | 2018 | 128 | 0.510 |
Why?
|
Clostridium Infections | 3 | 2018 | 562 | 0.510 |
Why?
|
Colonic Diseases | 1 | 2017 | 204 | 0.510 |
Why?
|
Disease Progression | 8 | 2019 | 13674 | 0.500 |
Why?
|
Vegetables | 2 | 2020 | 1199 | 0.500 |
Why?
|
Aged | 63 | 2024 | 171786 | 0.490 |
Why?
|
Heme | 1 | 2017 | 316 | 0.490 |
Why?
|
Feces | 9 | 2024 | 1510 | 0.490 |
Why?
|
Alcohol Drinking | 3 | 2022 | 4045 | 0.480 |
Why?
|
Feeding Behavior | 4 | 2022 | 3205 | 0.480 |
Why?
|
Androgens | 1 | 2022 | 1285 | 0.480 |
Why?
|
Obesity | 7 | 2021 | 13091 | 0.470 |
Why?
|
Male | 92 | 2024 | 365203 | 0.460 |
Why?
|
Abdominal Pain | 3 | 2019 | 1070 | 0.460 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 947 | 0.450 |
Why?
|
Acetaminophen | 1 | 2018 | 556 | 0.450 |
Why?
|
Health Resources | 1 | 2020 | 951 | 0.450 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2276 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 7 | 2022 | 18068 | 0.430 |
Why?
|
Smoking | 9 | 2022 | 9094 | 0.430 |
Why?
|
Colonic Polyps | 3 | 2023 | 557 | 0.420 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2020 | 4356 | 0.420 |
Why?
|
Testosterone | 3 | 2022 | 2493 | 0.410 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 748 | 0.410 |
Why?
|
Organometallic Compounds | 2 | 2018 | 648 | 0.410 |
Why?
|
Young Adult | 37 | 2024 | 60131 | 0.410 |
Why?
|
Bacterial Infections | 1 | 2021 | 1397 | 0.410 |
Why?
|
Weight Gain | 2 | 2020 | 2359 | 0.390 |
Why?
|
Metagenomics | 3 | 2024 | 474 | 0.390 |
Why?
|
Vitamin B 12 | 1 | 2015 | 529 | 0.380 |
Why?
|
Cohort Studies | 32 | 2023 | 41808 | 0.380 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 3253 | 0.380 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 584 | 0.380 |
Why?
|
Menopause | 2 | 2018 | 1656 | 0.380 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4207 | 0.380 |
Why?
|
Microsatellite Instability | 1 | 2015 | 726 | 0.380 |
Why?
|
Risk Assessment | 24 | 2021 | 24333 | 0.380 |
Why?
|
Health Surveys | 8 | 2018 | 4055 | 0.370 |
Why?
|
Body Mass Index | 8 | 2018 | 13055 | 0.370 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2023 | 16053 | 0.360 |
Why?
|
Adenoma | 4 | 2023 | 2163 | 0.350 |
Why?
|
Age of Onset | 7 | 2020 | 3346 | 0.340 |
Why?
|
Multivariate Analysis | 15 | 2018 | 12095 | 0.330 |
Why?
|
Postmenopause | 3 | 2017 | 2519 | 0.330 |
Why?
|
Patient Compliance | 1 | 2020 | 2701 | 0.330 |
Why?
|
Adolescent | 33 | 2024 | 89244 | 0.320 |
Why?
|
Colon | 4 | 2024 | 1803 | 0.310 |
Why?
|
Biopsy | 13 | 2024 | 6805 | 0.310 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 381 | 0.310 |
Why?
|
Nurses | 7 | 2021 | 2501 | 0.300 |
Why?
|
Health Care Costs | 2 | 2023 | 3270 | 0.300 |
Why?
|
Risk | 6 | 2023 | 9621 | 0.290 |
Why?
|
Pensions | 2 | 2019 | 16 | 0.290 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2021 | 2336 | 0.280 |
Why?
|
Life Style | 3 | 2017 | 3931 | 0.280 |
Why?
|
Chronic Disease | 4 | 2022 | 9384 | 0.270 |
Why?
|
Adiposity | 1 | 2017 | 1895 | 0.270 |
Why?
|
Dietary Fiber | 3 | 2023 | 767 | 0.270 |
Why?
|
Remission Induction | 3 | 2024 | 2408 | 0.270 |
Why?
|
United States | 26 | 2024 | 73186 | 0.270 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1811 | 0.270 |
Why?
|
Absenteeism | 2 | 2020 | 247 | 0.260 |
Why?
|
Constipation | 2 | 2024 | 570 | 0.260 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15951 | 0.260 |
Why?
|
Odds Ratio | 8 | 2024 | 9684 | 0.250 |
Why?
|
Logistic Models | 9 | 2018 | 13318 | 0.250 |
Why?
|
Irritable Bowel Syndrome | 2 | 2021 | 454 | 0.240 |
Why?
|
Age Factors | 7 | 2021 | 18435 | 0.240 |
Why?
|
Prognosis | 14 | 2021 | 30046 | 0.240 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5892 | 0.240 |
Why?
|
Metagenome | 3 | 2024 | 465 | 0.240 |
Why?
|
Estradiol | 2 | 2022 | 1952 | 0.240 |
Why?
|
Aged, 80 and over | 20 | 2021 | 59739 | 0.230 |
Why?
|
Hospitalization | 9 | 2021 | 10847 | 0.230 |
Why?
|
Siblings | 3 | 2023 | 828 | 0.230 |
Why?
|
Population Surveillance | 4 | 2020 | 2597 | 0.230 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4363 | 0.220 |
Why?
|
Quality of Life | 4 | 2021 | 13510 | 0.220 |
Why?
|
Motor Activity | 1 | 2013 | 2713 | 0.220 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3447 | 0.220 |
Why?
|
Hepatitis B, Chronic | 2 | 2019 | 413 | 0.220 |
Why?
|
Hip Fractures | 1 | 2012 | 997 | 0.220 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1941 | 0.210 |
Why?
|
Intestinal Mucosa | 3 | 2024 | 3044 | 0.200 |
Why?
|
Massachusetts | 5 | 2018 | 8894 | 0.200 |
Why?
|
Time Factors | 14 | 2021 | 40261 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8617 | 0.190 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 169 | 0.190 |
Why?
|
Diarrhea | 4 | 2021 | 1320 | 0.190 |
Why?
|
Sigmoidoscopy | 2 | 2019 | 150 | 0.180 |
Why?
|
Aspirin | 3 | 2020 | 3135 | 0.180 |
Why?
|
C-Reactive Protein | 4 | 2016 | 3859 | 0.180 |
Why?
|
Exercise | 1 | 2017 | 5954 | 0.180 |
Why?
|
Manitoba | 1 | 2020 | 24 | 0.180 |
Why?
|
Diet Surveys | 3 | 2020 | 1160 | 0.170 |
Why?
|
Intestine, Large | 1 | 2019 | 69 | 0.170 |
Why?
|
Second-Look Surgery | 1 | 2019 | 27 | 0.160 |
Why?
|
Work | 1 | 2020 | 195 | 0.160 |
Why?
|
Cecum | 1 | 2019 | 231 | 0.160 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 109 | 0.150 |
Why?
|
Bacteria | 3 | 2024 | 2216 | 0.150 |
Why?
|
Appendectomy | 2 | 2022 | 443 | 0.150 |
Why?
|
Ruminococcus | 1 | 2017 | 11 | 0.150 |
Why?
|
Comorbidity | 7 | 2021 | 10592 | 0.150 |
Why?
|
Antidiarrheals | 1 | 2018 | 46 | 0.150 |
Why?
|
Self Report | 4 | 2024 | 3773 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 708 | 0.150 |
Why?
|
Retrospective Studies | 20 | 2021 | 81903 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 2002 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 810 | 0.140 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
Unemployment | 1 | 2019 | 211 | 0.140 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2018 | 104 | 0.140 |
Why?
|
Mesalamine | 1 | 2018 | 134 | 0.140 |
Why?
|
Fruit | 2 | 2020 | 1165 | 0.140 |
Why?
|
Parkinson Disease | 2 | 2021 | 2895 | 0.140 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7478 | 0.140 |
Why?
|
Drug Monitoring | 2 | 2020 | 965 | 0.130 |
Why?
|
Phenotype | 3 | 2022 | 16731 | 0.130 |
Why?
|
Microsatellite Repeats | 2 | 2016 | 785 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 506 | 0.130 |
Why?
|
Fatigue | 2 | 2020 | 1557 | 0.130 |
Why?
|
Child Abuse | 1 | 2024 | 1091 | 0.130 |
Why?
|
Defecation | 1 | 2017 | 191 | 0.130 |
Why?
|
Patient Care Management | 1 | 2018 | 304 | 0.120 |
Why?
|
Child | 15 | 2024 | 80960 | 0.120 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2133 | 0.120 |
Why?
|
Appendicitis | 1 | 2022 | 689 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1514 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1064 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 251 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15661 | 0.120 |
Why?
|
Tetracycline | 1 | 2015 | 216 | 0.120 |
Why?
|
Laxatives | 1 | 2015 | 95 | 0.120 |
Why?
|
Rosacea | 1 | 2015 | 60 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.120 |
Why?
|
Cause of Death | 3 | 2020 | 3721 | 0.120 |
Why?
|
Ostomy | 1 | 2014 | 33 | 0.120 |
Why?
|
Anus Diseases | 1 | 2014 | 54 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14794 | 0.120 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 205 | 0.120 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.120 |
Why?
|
Genetic Loci | 2 | 2021 | 2630 | 0.120 |
Why?
|
Fecal Incontinence | 1 | 2017 | 246 | 0.110 |
Why?
|
Treatment Outcome | 15 | 2020 | 65480 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2019 | 863 | 0.110 |
Why?
|
Disability Evaluation | 2 | 2018 | 1839 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 888 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 558 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 358 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1119 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26395 | 0.110 |
Why?
|
Beverages | 1 | 2018 | 819 | 0.100 |
Why?
|
Steroids | 1 | 2018 | 938 | 0.100 |
Why?
|
Methotrexate | 1 | 2019 | 1723 | 0.100 |
Why?
|
Peptic Ulcer | 1 | 2014 | 215 | 0.100 |
Why?
|
Disabled Persons | 2 | 2019 | 1210 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1321 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 3 | 2016 | 1892 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12253 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2542 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2139 | 0.100 |
Why?
|
Antigen Presentation | 1 | 1997 | 1252 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1104 | 0.100 |
Why?
|
Iran | 1 | 2015 | 763 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 278 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1619 | 0.090 |
Why?
|
Zinc | 1 | 2015 | 677 | 0.090 |
Why?
|
Biological Products | 1 | 2021 | 947 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1033 | 0.090 |
Why?
|
Sleep | 3 | 2016 | 4820 | 0.090 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12801 | 0.090 |
Why?
|
Recurrence | 4 | 2016 | 8513 | 0.090 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.090 |
Why?
|
Vitamin D | 2 | 2016 | 3311 | 0.090 |
Why?
|
Fetus | 1 | 1997 | 1882 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13698 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 734 | 0.080 |
Why?
|
Child, Preschool | 7 | 2024 | 42683 | 0.080 |
Why?
|
Mortality | 1 | 2021 | 2914 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1812 | 0.080 |
Why?
|
Geography | 1 | 2012 | 654 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 489 | 0.080 |
Why?
|
Mucous Membrane | 2 | 2023 | 659 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11932 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1204 | 0.080 |
Why?
|
Women's Health | 1 | 2019 | 2081 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2241 | 0.080 |
Why?
|
Affect | 1 | 2016 | 1500 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2167 | 0.080 |
Why?
|
Smoking Cessation | 2 | 2018 | 2085 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9756 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2649 | 0.080 |
Why?
|
Breast Feeding | 2 | 2014 | 1364 | 0.070 |
Why?
|
Gene Frequency | 1 | 2015 | 3626 | 0.070 |
Why?
|
Vitamins | 1 | 2016 | 1638 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 13021 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3235 | 0.070 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1962 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1389 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2024 | 1439 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2945 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1381 | 0.070 |
Why?
|
Iron | 1 | 2015 | 1814 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4339 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1064 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3232 | 0.060 |
Why?
|
Heart Failure | 2 | 2023 | 11879 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2019 | 26428 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2340 | 0.060 |
Why?
|
Critical Illness | 2 | 2016 | 2754 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20776 | 0.060 |
Why?
|
Length of Stay | 2 | 2016 | 6526 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7603 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3238 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2121 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3008 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1960 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1505 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3838 | 0.060 |
Why?
|
Gastrointestinal Transit | 1 | 2024 | 101 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2017 | 3985 | 0.050 |
Why?
|
Infant, Premature | 1 | 2013 | 2123 | 0.050 |
Why?
|
Lung | 2 | 2019 | 10099 | 0.050 |
Why?
|
Echinococcosis | 1 | 2002 | 32 | 0.050 |
Why?
|
Common Variable Immunodeficiency | 1 | 2024 | 100 | 0.050 |
Why?
|
Genotype | 4 | 2018 | 13048 | 0.050 |
Why?
|
Macrophages | 1 | 1997 | 5801 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1606 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1968 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 399 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3982 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1388 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7460 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6401 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2121 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3800 | 0.050 |
Why?
|
Peptide Elongation Factors | 1 | 2001 | 60 | 0.050 |
Why?
|
Morbidity | 2 | 2018 | 1757 | 0.050 |
Why?
|
DNA Methylation | 2 | 2016 | 4432 | 0.050 |
Why?
|
Infant | 5 | 2024 | 36556 | 0.040 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9377 | 0.040 |
Why?
|
Treatment Failure | 2 | 2016 | 2664 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 7081 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4544 | 0.040 |
Why?
|
Pacific Ocean | 1 | 2019 | 16 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2020 | 12467 | 0.040 |
Why?
|
Sex Factors | 3 | 2018 | 10633 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6346 | 0.040 |
Why?
|
Insurance, Disability | 1 | 2018 | 26 | 0.040 |
Why?
|
Thrombospondins | 1 | 2019 | 196 | 0.040 |
Why?
|
Blood | 1 | 2021 | 599 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1336 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1855 | 0.040 |
Why?
|
Immunologic Factors | 2 | 2019 | 1597 | 0.040 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2001 | 497 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 395 | 0.040 |
Why?
|
Enterocytes | 1 | 2019 | 219 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 800 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20245 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13594 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3811 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 360 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5891 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6320 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9549 | 0.040 |
Why?
|
Animals | 4 | 2018 | 169335 | 0.040 |
Why?
|
Asia | 1 | 2019 | 630 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10765 | 0.040 |
Why?
|
Liver | 3 | 2021 | 7578 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1997 | 318 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3810 | 0.030 |
Why?
|
Proteomics | 2 | 2021 | 3914 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4919 | 0.030 |
Why?
|
Depression | 2 | 2016 | 8231 | 0.030 |
Why?
|
Hybridomas | 1 | 1997 | 444 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 915 | 0.030 |
Why?
|
Butyrates | 1 | 2017 | 167 | 0.030 |
Why?
|
Ileitis | 1 | 2016 | 40 | 0.030 |
Why?
|
Capsules | 1 | 2016 | 193 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9264 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Weight Loss | 2 | 2019 | 2721 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12873 | 0.030 |
Why?
|
Freezing | 1 | 2016 | 311 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3200 | 0.030 |
Why?
|
Hormones | 1 | 2019 | 870 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2277 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1997 | 1769 | 0.030 |
Why?
|
North America | 1 | 2018 | 1290 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1265 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1320 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8664 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7453 | 0.030 |
Why?
|
Gastritis | 1 | 2016 | 199 | 0.030 |
Why?
|
Medical History Taking | 1 | 2018 | 779 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1133 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 4300 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15889 | 0.030 |
Why?
|
Brain Diseases | 1 | 2002 | 1558 | 0.030 |
Why?
|
Survival | 1 | 2013 | 160 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1473 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 526 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10115 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2417 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2015 | 446 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 925 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2280 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 1009 | 0.030 |
Why?
|
Retirement | 1 | 2014 | 198 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36854 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 524 | 0.030 |
Why?
|
Integrins | 1 | 2017 | 843 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 585 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 796 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15471 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2875 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 395 | 0.030 |
Why?
|
Biostatistics | 1 | 2014 | 165 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5801 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2015 | 606 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 840 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2024 | 3702 | 0.020 |
Why?
|
Genetic Markers | 1 | 2018 | 2604 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3438 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1675 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1506 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2018 | 2360 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3441 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1836 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1866 | 0.020 |
Why?
|
Efficiency | 1 | 2014 | 480 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1445 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14201 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10276 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1904 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1364 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 2014 | 380 | 0.020 |
Why?
|
Women | 1 | 2012 | 225 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3116 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3629 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4651 | 0.020 |
Why?
|
Adiponectin | 1 | 2016 | 1117 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1997 | 1667 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2001 | 2682 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2843 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 3780 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22389 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17591 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2646 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1812 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4862 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1197 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1063 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4352 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1894 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3608 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6232 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 828 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1408 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4040 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1890 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1769 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1114 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2209 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2423 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1498 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1542 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2748 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3139 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2059 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3628 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3671 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5323 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6901 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 6991 | 0.010 |
Why?
|
Inpatients | 1 | 2016 | 2569 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4095 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7148 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3383 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8094 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15604 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9618 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2493 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8748 | 0.010 |
Why?
|
Iraq | 1 | 2002 | 93 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3904 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 365 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4672 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6610 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6435 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12174 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6214 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5928 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9442 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10868 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2001 | 149 | 0.010 |
Why?
|
Transcriptional Elongation Factors | 1 | 2001 | 169 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6673 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7885 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10400 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2001 | 1162 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4456 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 943 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2001 | 907 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2749 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2179 | 0.010 |
Why?
|
RNA Polymerase II | 1 | 2001 | 549 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4168 | 0.010 |
Why?
|
Mammals | 1 | 2001 | 1136 | 0.010 |
Why?
|
Mice | 2 | 2001 | 82072 | 0.010 |
Why?
|
Reoperation | 1 | 2002 | 4342 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2001 | 1726 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2001 | 1469 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30266 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6512 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 19023 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13427 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2001 | 5151 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17629 | 0.000 |
Why?
|
Rats | 1 | 2001 | 23786 | 0.000 |
Why?
|
Signal Transduction | 1 | 2005 | 23653 | 0.000 |
Why?
|